Causes of early mortality after liver transplantation: A twenty-years single centre experience;Mortalité trois mois après transplantation hépatique: Étude monocentrique sur une période de vingt ans

Annales Francaises d'Anesthesie et de Reanimation

Volumn 30, Issue 12, 2011, Pages 899-904

  Jung, B ^a   Cisse, M ^a   Chanques, G ^a   Arsac, E ^a   Bismuth, M ^a   Panaro, F ^a   Perrigault, P F ^a   Souche, B ^a   Gallix, B ^a   Verzilli, D ^a   Delay, J M ^a   Navarro, F ^a   Pageaux, G P ^a   Jaber, S ^a  

^a HÔPITAL SAINT ELOI   (France)

Author keywords

Liver transplantation; Postoperative complication; Sepsis; Stroke

Indexed keywords

ALCOHOL LIVER CIRRHOSIS; ARTICLE; BILIARY CIRRHOSIS; CAUSE OF DEATH; DEMOGRAPHY; EXPERIENCE; GRAFT DYSFUNCTION; HEART DISEASE; HEMORRHAGIC SHOCK; HEPATITIS C; HUMAN; INTENSIVE CARE UNIT; INTRAOPERATIVE PERIOD; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MORTALITY; MULTIPLE ORGAN FAILURE; NEUROLOGIC DISEASE; OBSERVATIONAL STUDY; ORGAN DONOR; PREOPERATIVE PERIOD; RETROSPECTIVE STUDY; SEPSIS; TREATMENT INDICATION;

CAUSE OF DEATH; FEMALE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 83255187153     PISSN: 07507658     EISSN: 17696623     Source Type: Journal    
DOI: 10.1016/j.annfar.2011.06.014     Document Type: Article

References (34)

1. Mazzaferro V., Regalia E., Doci R., Andreola S., Pulvirenti A., Bozzetti F., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996, 334:693-699.
2. Adam R., Cailliez V., Majno P., Karam V., McMaster P., Caine R.Y., et al. Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study. Lancet 2000, 356:621-627.
3. Smith C.M., Davies D.B., McBride M.A. Liver transplantation in the United States: a report from the UNOS Liver Transplant Registry. Clin Transpl 1999, 13:23-34.
4. Burroughs A.K., Sabin C.A., Rolles K., Delvart V., Karam V., Buckels J., et al. 3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome. Lancet 2006, 367:225-232.
5. Avolio A.W., Agnes S., Chirico A.S., Montemagno S., Castagneto M. Preoperative recipient data and immunosuppression levels are predictive of early patient survival after liver transplantation. Transpl Int 1998, 11(Suppl 1):S224-S230.
6. Bilbao I., Armadans L., Lazaro J.L., Hidalgo E., Castells L., Margarit C. Predictive factors for early mortality following liver transplantation. Clin Transplant 2003, 17:401-411.
7. Otero-Ravina F., Rodriguez-Martinez M., Selles C.F., Gutierrez M.G., Blanco M.D., de Rituerto S.T., et al. Analysis of survival after liver transplantation in Galicia, Spain. Transplant Proc 2005, 37:3913-3915.
8. Qian Y.B., Cheng G.H., Huang J.F. Multivariate regression analysis on early mortality after orthotopic liver transplantation. World J Gastroenterol 2002, 8:128-130.
9. Jain A., Reyes J., Kashyap R., Dodson S.F., Demetris A.J., Ruppert K., et al. Long-term survival after liver transplantation in 4,000 consecutive patients at a single centre. Ann Surg 2000, 232:490-500.
10. Kashyap R., Jain A., Reyes J., Demetris A.J., Elmagd K.A., Dodson S.F., et al. Causes of death after liver transplantation in 4000 consecutive patients: 2 to 19 year follow-up. Transplant Proc 2001, 33:1482-1483.
11. Vogt D.P., Henderson J.M., Carey W.D., Barnes D. The long-term survival and causes of death in patients who survive at least 1 year after liver transplantation. Surgery 2002, 132:775-780. [Discussion 80].
12. Gaynor J.J., Moon J.I., Kato T., Nishida S., Selvaggi G., Levi D.M., et al. A cause-specific hazard rate analysis of prognostic factors among 877 adults who received primary orthotopic liver transplantation. Transplantation 2007, 84:155-165.
13. Olthoff K.M., Kulik L., Samstein B., Kaminski M., Abecassis M., Emond J., et al. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transpl 2010, 16:943-949.
14. Pageaux G.P., Faure S., Bouyabrine H., Bismuth M., Assenat E. Long-term outcomes of liver transplantation: diabetes mellitus. Liver Transpl 2009, 15(Suppl 2):S79-S82.
15. Pageaux G.P., Rostaing L., Calmus Y., Duvoux C., Vanlemmens C., Hardgwissen J., et al. Mycophenolate mofetil in combination with reduction of calcineurin inhibitors for chronic renal dysfunction after liver transplantation. Liver Transpl 2006, 12:1755-1760.
16. Lama C., Ramos E., Figueras J., Casanovas T., Rafecas A., Xiol X., et al. Predictive factors for postoperatory, early and late mortality in liver transplants. Transplant Proc 2002, 34:283-286.
17. Lama C., Ramos E., Figueras J., Rafecas A., Fabregat J., Torras J., et al. Causes of mortality after liver transplantation: period of main incidence. Transplant Proc 2002, 34:287-289.
18. Fishman J.A. Infection in solid-organ transplant recipients. N Engl J Med 2007, 357:2601-2614.
19. Paugam-Burtz C., Chatelon J., Follin A., Rossel N., Chanques G., Jaber S. Perioperative anaesthetic practices in liver transplantation in France: evolution between 2004 and 2008. Ann Fr Anesth Reanim 2010, 29:419-424.
20. Vandecasteele E., De Waele J., Vandijck D., Blot S., Vogelaers D., Rogiers X., et al. Antimicrobial prophylaxis in liver transplant patients - a multicenter survey endorsed by the European Liver and Intestine Transplant Association. Transpl Int 2010, 23:182-190.
21. Hlava N., Niemann C.U., Gropper M.A., Melcher M.L. Postoperative infectious complications of abdominal solid organ transplantation. J Intensive Care Med 2009, 24:3-17.
22. Jung B., Embriaco N., Roux F., Forel J.M., Demory D., Allardet-Servent J., et al. Microbiogical data, but not procalcitonin improve the accuracy of the clinical pulmonary infection score. Intensive Care Med 2010, 36:790-798.
23. Luyt C.E., Combes A., Reynaud C., Hekimian G., Nieszkowska A., Tonnellier M., et al. Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia. Intensive Care Med 2008, 34:1434-1440.
24. Perrakis A., Yedibela S., Schellerer V., Hohenberger W., Muller V. Procalcitonin in the setting of complicated postoperative course after liver transplantation. Transplant Proc 2010, 42:4187-4190.
25. van den Broek M.A., Olde Damink S.W., Winkens B., Broelsch C.E., Malago M., Paul A., et al. Procalcitonin as a prognostic marker for infectious complications in liver transplant recipients in an intensive care unit. Liver Transpl 2010, 16:402-410.
26. Paugam-Burtz C., Albuquerque M., Baron G., Bert F., Voitot H., Delefosse D., et al. Plasma proteome to look for diagnostic biomarkers of early bacterial sepsis after liver transplantation: a preliminary study. Anesthesiology 2010, 112:926-935.
27. Boillot O., Mayer D.A., Boudjema K., Salizzoni M., Gridelli B., Filipponi F., et al. Corticosteroid-free immunosuppression with tacrolimus following induction with daclizumab: a large randomised clinical study. Liver Transpl 2005, 11:61-67.
28. Paugam-Burtz C., Janny S., Delefosse D., Dahmani S., Dondero F., Mantz J., et al. Prospective validation of the " fifty-fifty" criteria as an early and accurate predictor of death after liver resection in intensive care unit patients. Ann Surg 2009, 249:124-128.
29. McCaughan G.W., Herkes R., Powers B., Rickard K., Gallagher N.D., Thompson J.F., et al. Thrombocytopenia post liver transplantation. Correlations with pre-operative platelet count, blood transfusion requirements, allograft function and outcome. J Hepatol 1992, 16:16-22.
30. Saner F., Gu Y., Minouchehr S., Ilker K., Fruhauf N.R., Paul A., et al. Neurological complications after cadaveric and living donor liver transplantation. J Neurol 2006, 253:612-617.
31. Senzolo M., Ferronato C., Burra P. Neurologic complications after solid organ transplantation. Transpl Int 2009, 22:269-278.
32. Cescon M., Sugawara Y., Takayama T., Seyama Y., Sano K., Imamura H., et al. Role of splenectomy in living-donor liver transplantation for adults. Hepatogastroenterology 2002, 49:721-723.
33. Transfusion de plaquettes - Transfusion de granulocytes - Recommandations de Bonnes Pratiques de l'Afssaps ; 2005. http://agmed.sante.gouv.fr/htm/5/rbp/tpf.htm.
34. Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 2006;105:198-208.